Literature DB >> 27406742

β-Cell dedifferentiation, reduced duct cell plasticity, and impaired β-cell mass regeneration in middle-aged rats.

Noèlia Téllez1, Marina Vilaseca2, Yasmina Martí3, Arturo Pla3, Eduard Montanya4.   

Abstract

Limitations in β-cell regeneration potential in middle-aged animals could contribute to the increased risk to develop diabetes associated with aging. We investigated β-cell regeneration of middle-aged Wistar rats in response to two different regenerative stimuli: partial pancreatectomy (Px + V) and gastrin administration (Px + G). Pancreatic remnants were analyzed 3 and 14 days after surgery. β-Cell mass increased in young animals after Px and was further increased after gastrin treatment. In contrast, β-cell mass did not change after Px or after gastrin treatment in middle-aged rats. β-Cell replication and individual β-cell size were similarly increased after Px in young and middle-aged animals, and β-cell apoptosis was not modified. Nuclear immunolocalization of neurog3 or nkx6.1 in regenerative duct cells, markers of duct cell plasticity, was increased in young but not in middle-aged Px rats. The pancreatic progenitor-associated transcription factors neurog3 and sox9 were upregulated in islet β-cells of middle-aged rats and further increased after Px. The percentage of chromogranin A+/hormone islet cells was significantly increased in the pancreases of middle-aged Px rats. In summary, the potential for compensatory β-cell hyperplasia and hypertrophy was retained in middle-aged rats, but β-cell dedifferentiation and impaired duct cell plasticity limited β-cell regeneration.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  aging; duct cell plasticity; gastrin; regeneration; β-cell dedifferentiation; β-cell replication

Mesh:

Substances:

Year:  2016        PMID: 27406742     DOI: 10.1152/ajpendo.00502.2015

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  7 in total

Review 1.  Inadequate β-cell mass is essential for the pathogenesis of type 2 diabetes.

Authors:  Gordon C Weir; Jason Gaglia; Susan Bonner-Weir
Journal:  Lancet Diabetes Endocrinol       Date:  2020-01-29       Impact factor: 32.069

Review 2.  Regenerative approaches to preserve pancreatic β-cell mass and function in diabetes pathogenesis.

Authors:  Maria Fernanda Desentis-Desentis
Journal:  Endocrine       Date:  2021-11-25       Impact factor: 3.633

3.  Purification of replicating pancreatic β-cells for gene expression studies.

Authors:  Reyes Carballar; Maria de Lluc Canyelles; Claudia Fernández; Yasmina Martí; Sarah Bonnin; Esther Castaño; Eduard Montanya; Noèlia Téllez
Journal:  Sci Rep       Date:  2017-12-13       Impact factor: 4.379

Review 4.  Endogenous Pancreatic β Cell Regeneration: A Potential Strategy for the Recovery of β Cell Deficiency in Diabetes.

Authors:  Fan Zhong; Yan Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-20       Impact factor: 5.555

5.  Salsalate Prevents β-Cell Dedifferentiation in OLETF Rats with Type 2 Diabetes through Notch1 Pathway.

Authors:  Fei Han; Xiaochen Li; Juhong Yang; Haiyi Liu; Yi Zhang; Xiaoyun Yang; Shaohua Yang; Bai Chang; Liming Chen; Baocheng Chang
Journal:  Aging Dis       Date:  2019-08-01       Impact factor: 6.745

6.  β cell aging and age-related diabetes.

Authors:  Min Zhu; Xiaohong Liu; Wen Liu; Yanrong Lu; Jingqiu Cheng; Younan Chen
Journal:  Aging (Albany NY)       Date:  2021-03-03       Impact factor: 5.682

Review 7.  A Brief Review of the Mechanisms of β-Cell Dedifferentiation in Type 2 Diabetes.

Authors:  Phyu-Phyu Khin; Jong-Han Lee; Hee-Sook Jun
Journal:  Nutrients       Date:  2021-05-10       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.